Analyst Ratings for Revance Therapeutic (RVNC) [Neutrals]
RVNC Rating Summary
RVNC Price Target Summary
- Highest: $30.00 (Stifel)
- Lowest: $9.00 (Mizuho)
- Average: $14.63
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$14.63 (+285.9%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 66%
Avg. $ Target:
$14.63 (+285.9%)
* Over Last 12-Mos
Rating Score: 6.1 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/29/2024 | Mizuho | Vamil Divan | Downgrade | Neutral (Buy) |
9.00 (16.00) |
5.93 (3.79) |
-36.09% | Details |
| 1/9/2024 | Goldman Sachs » Updated 3/1/2024 |
Chris Shibutani | Downgrade | Neutral (Buy) |
9.00 (8.00) |
7.05 (3.79) |
-46.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
